MERITAGE PORTFOLIO MANAGEMENT - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
MERITAGE PORTFOLIO MANAGEMENT ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$690
+23.2%
25,319
+0.6%
0.05%
+27.5%
Q2 2023$560
+32.1%
25,173
+28.5%
0.04%
+25.0%
Q1 2023$424
+6.3%
19,588
-0.4%
0.03%
+3.2%
Q4 2022$399
-99.9%
19,662
+3.2%
0.03%
-24.4%
Q3 2022$489,000
+11.6%
19,055
+3.4%
0.04%
+20.6%
Q2 2022$438,000
+3.1%
18,422
-2.4%
0.03%
+30.8%
Q1 2022$425,000
+104.3%
18,878
+79.8%
0.03%
+116.7%
Q4 2021$208,00010,5000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders